세포배양용 첨가제 시장의 성장은 어떤 요인에 의해 이루어지나요?

세포배양용 첨가제 시장의 성장은 바이오의약품에 대한 수요 증가, 세포배양 기술의 발전, 맞춤형 의료 및 재생의료에 대한 관심 증가에 힘입은 바 큽니다.

시장보고서

상품코드

1986595

세포배양용 첨가제 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Culture Supplements Market Size, Share & Trends Analysis Report By Product (Protein-Based & Recombinant, Chemically Defined), By Application (Cell & Gene Therapy, Drug Discovery), By End Use, By Region, And Segment Forecasts, 2026 - 2033

발행일: 2026년 02월 | 리서치사: 구분자

Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 5,950

￦ 8,927,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 6,950

￦ 10,427,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 8,950

￦ 13,428,000

※ 부가세 별도

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포배양용 첨가제 시장 요약

세계의 세포배양용 첨가제 시장 규모는 2025년에 27억 4,000만 달러로 추계되며, 2033년까지 71억 4,000만 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 13.28%로 확대할 전망입니다.

이러한 성장은 바이오의약품에 대한 수요 증가, 세포배양 기술의 발전, 맞춤형 의료 및 재생의료에 대한 관심 증가에 힘입은 바 큽니다.

자주 묻는 질문

세포배양용 첨가제 시장 규모는 어떻게 예측되나요?
- 세계의 세포배양용 첨가제 시장 규모는 2025년에 27억 4,000만 달러로 추계되며, 2033년까지 71억 4,000만 달러에 달할 것으로 예측됩니다. 예측기간 동안 CAGR은 13.28%로 확대할 전망입니다.
세포배양용 첨가제 시장의 성장은 어떤 요인에 의해 이루어지나요?
- 세포배양용 첨가제 시장의 성장은 바이오의약품에 대한 수요 증가, 세포배양 기술의 발전, 맞춤형 의료 및 재생의료에 대한 관심 증가에 힘입은 바 큽니다.

The global cell culture supplements market size was estimated at USD 2.74 billion in 2025 and is projected to reach USD 7.14 billion by 2033, expanding at a CAGR of 13.28% from 2026 to 2033. This growth is driven by increasing demand for biopharmaceuticals, advancements in cell culture technology, and the rising focus on personalized medicine and regenerative therapies.

Global Cell Culture Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell culture supplements market report based on product, application, end use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Serum-Based Supplements
Protein-Based & Recombinant Supplements
Chemically Defined Supplements
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Biopharmaceutical Manufacturing
Cell & Gene Therapy
Drug Discovery
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Cell Culture Media Manufacturers
Pharmaceutical & Biotechnology Companies
CDMOs/ CMOs & CROs
Academic & Research Institutes
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Application Segment
- 1.2.3. End Use Segment
1.3. Information Analysis
- 1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Cell Culture Supplements Market Variables & Trends

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Advancements in 3D cell culture and organoid models
  - 3.2.1.2. Rapid growth in regenerative medicine and stem cell research
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost of GMP-grade and specialty supplements
  - 3.2.2.2. Regulatory and standardization challenges
3.3. Cell Culture Supplements Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis

Chapter 4. Cell Culture Supplements Market: Product Estimates & Trend Analysis

4.1. Product Segment Dashboard
4.2. Global Cell Culture Supplements Market Product Movement Analysis
4.3. Global Cell Culture Supplements Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Serum-Based Supplements
- 4.4.1. Serum-Based Supplements market estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Protein-Based & Recombinant Supplements
- 4.5.1. Protein-Based & Recombinant Supplements market estimates and forecasts, 2021 - 2033 (USD Million)
4.6. Chemically Defined Supplements
- 4.6.1. Chemically Defined Supplements market estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Others
- 4.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cell Culture Supplements Market: Application Estimates & Trend Analysis

5.1. Application Segment Dashboard
5.2. Global Cell Culture Supplements Market Application Movement Analysis
5.3. Global Cell Culture Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Biopharmaceutical Manufacturing
- 5.4.1. Biopharmaceuticals manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Cell & Gene Therapy
- 5.5.1. Cell & gene therapy market estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Drug Discovery
- 5.6.1. Drug discovery market estimates and forecasts, 2021 - 2033 (USD Million)
5.7. Others
- 5.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cell Culture Supplements Market: End Use Estimates & Trend Analysis

6.1. End Use Segment Dashboard
6.2. Global Cell Culture Supplements Market End Use Movement Analysis
6.3. Global Cell Culture Supplements Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Cell Culture Media Manufacturers
- 6.4.1. Cell culture media manufacturers companies market estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Pharmaceutical & Biotechnology Companies
- 6.5.1. Pharmaceuticals & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
6.6. CDMOs/ CMOs & CROs
- 6.6.1. CDMOs/ CMOs & CROs market estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Academic & Research Institutes
- 6.7.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cell Culture Supplements Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
- 7.4.1. U.S.
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Competitive scenario
  - 7.4.1.3. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Canada
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Competitive scenario
  - 7.4.2.3. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Mexico
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Competitive scenario
  - 7.4.3.3. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
7.5. Europe
- 7.5.1. UK
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Competitive scenario
  - 7.5.1.3. UK market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Germany
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. France
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. France market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. Italy
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Competitive scenario
  - 7.5.4.3. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Spain
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Competitive scenario
  - 7.5.5.3. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Norway
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Competitive scenario
  - 7.5.6.3. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Sweden
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Competitive scenario
  - 7.5.7.3. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Denmark
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Competitive scenario
  - 7.5.8.3. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
- 7.6.1. Japan
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Competitive scenario
  - 7.6.1.3. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.2. China
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Competitive scenario
  - 7.6.2.3. China market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. India
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Competitive scenario
  - 7.6.3.3. India market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.4. Australia
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Competitive scenario
  - 7.6.4.3. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Competitive scenario
  - 7.6.5.3. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Competitive scenario
  - 7.6.6.3. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
- 7.7.1. Brazil
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Competitive scenario
  - 7.7.1.3. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Argentina
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Competitive scenario
  - 7.7.2.3. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
7.8. MEA
- 7.8.1. South Africa
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Competitive scenario
  - 7.8.1.3. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.2. Saudi Arabia
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Competitive scenario
  - 7.8.2.3. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.3. UAE
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Competitive scenario
  - 7.8.3.3. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.4. Kuwait
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Competitive scenario
  - 7.8.4.3. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Company Profiles/Listing
- 8.4.1. Merck KGaA
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product/Service benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Thermo Fisher Scientific Inc.
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product/Service benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. HiMedia Laboratories
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product/Service benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. Danaher
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product/Service benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. Sartorius AG
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product/Service benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. Corning Inc.
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product/Service benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. R&D Systems (Bio-Techne)
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product/Service benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. STEMCELL Technologies
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product/Service benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Repligen Corporation
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product/Service benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Proteintech Group, Inc
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product/Service benchmarking
  - 8.4.10.4. Strategic initiatives

세포배양용 첨가제 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Culture Supplements Market Size, Share & Trends Analysis Report By Product (Protein-Based & Recombinant, Chemically Defined), By Application (Cell & Gene Therapy, Drug Discovery), By End Use, By Region, And Segment Forecasts, 2026 - 2033

세포배양용 첨가제 시장 요약

자주 묻는 질문

목차

제1장 분석 방법·범위

제2장 개요

제3장 세포배양용 첨가제 시장 : 변동 요인·동향·범위

제4장 세포배양용 첨가제 시장 : 제품별 추정·동향 분석

제5장 세포배양용 첨가제 시장 : 용도별 추정·동향 분석

제6장 세포배양용 첨가제 시장 : 최종 용도별 추정·동향 분석

제7장 세포배양용 첨가제 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

Cell Culture Supplements Market Summary

Table of Contents